Centrum Medyczne ENEL-MED (FRA:E19) Cyclically Adjusted Revenue per Share: €5.43 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:E19 Centrum Medyczne ENEL-MED SA FRA:E19
76 GF Score
Price €4.24
GF Value €5.39
! 5 Warning Signs
View Full Analysis

What is Centrum Medyczne ENEL-MED Cyclically Adjusted Revenue per Share?

Centrum Medyczne ENEL-MED FRA:E19 -0.47% 76 Cyclically Adjusted Revenue per Share is €5.43 as of Mar. 2026. GuruFocus rates FRA:E19 with a GF Score™ of 76/100 and a GF Value™ of €5.39. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Centrum Medyczne ENEL-MED's adjusted revenue per share for the three months ended in Mar. 2026 was €1.663. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €5.43 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Centrum Medyczne ENEL-MED's average Cyclically Adjusted Revenue Growth Rate was 10.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Centrum Medyczne ENEL-MED was 14.90% per year. The lowest was -9.30% per year. And the median was 10.90% per year.

As of today (2026-07-29), Centrum Medyczne ENEL-MED's current stock price is €4.24. Centrum Medyczne ENEL-MED's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €5.43. Centrum Medyczne ENEL-MED's Cyclically Adjusted PS Ratio of today is 0.78.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Centrum Medyczne ENEL-MED was 1.52. The lowest was 0.52. And the median was 0.92.


Centrum Medyczne ENEL-MED  (FRA:E19) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Centrum Medyczne ENEL-MED's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.24/5.43
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Centrum Medyczne ENEL-MED was 1.52. The lowest was 0.52. And the median was 0.92.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Centrum Medyczne ENEL-MED Cyclically Adjusted Revenue per Share Related Terms


Centrum Medyczne ENEL-MED Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Centrum Medyczne ENEL-MED's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centrum Medyczne ENEL-MED Cyclically Adjusted Revenue per Share Chart

Centrum Medyczne ENEL-MED Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 4.91 5.49

Centrum Medyczne ENEL-MED Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.38 5.17 5.87 5.49 5.43

FRA:E19 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Centrum Medyczne ENEL-MED's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centrum Medyczne ENEL-MED Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Centrum Medyczne ENEL-MED's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Centrum Medyczne ENEL-MED's Cyclically Adjusted PS Ratio falls into.


FRA:E19
76GF Score
Centrum Medyczne ENEL-MED SA FRA:E19
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Centrum Medyczne ENEL-MED Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Centrum Medyczne ENEL-MED's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.663/163.0700*163.0700
=1.663

Current CPI (Mar. 2026) = 163.0700.

Centrum Medyczne ENEL-MED Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.662 99.552 1.084
201609 0.642 99.064 1.057
201612 0.694 100.366 1.128
201703 0.742 101.018 1.198
201706 0.768 101.180 1.238
201709 0.757 101.343 1.218
201712 0.925 102.564 1.471
201803 0.937 102.564 1.490
201806 0.838 103.378 1.322
201809 0.889 103.378 1.402
201812 0.962 103.785 1.512
201903 0.982 104.274 1.536
201906 1.008 105.983 1.551
201909 0.988 105.983 1.520
201912 1.082 107.123 1.647
202003 1.031 109.076 1.541
202006 0.868 109.402 1.294
202009 1.024 109.320 1.527
202012 0.822 109.565 1.223
202103 1.099 112.658 1.591
202106 0.995 113.960 1.424
202109 0.996 115.588 1.405
202112 0.936 119.088 1.282
202203 0.941 125.031 1.227
202206 0.869 131.705 1.076
202209 0.890 135.531 1.071
202212 1.095 139.113 1.284
202303 1.148 145.950 1.283
202306 1.260 147.009 1.398
202309 1.247 146.113 1.392
202312 1.330 147.741 1.468
202403 1.494 149.044 1.635
202406 1.623 150.997 1.753
202409 1.501 153.439 1.595
202412 1.556 154.660 1.641
202503 1.672 157.021 1.736
202506 1.616 157.509 1.673
202509 1.750 158.000 1.806
202512 1.851 158.320 1.907
202603 1.663 163.070 1.663

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €5.43 mean?
Centrum Medyczne ENEL-MED (FRA:E19) has a Cyclically Adjusted Revenue per Share of €5.43 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Centrum Medyczne ENEL-MED and its competitors.
Is Centrum Medyczne ENEL-MED's Cyclically Adjusted Revenue per Share too high?
Centrum Medyczne ENEL-MED's current Cyclically Adjusted Revenue per Share is €5.43. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Centrum Medyczne ENEL-MED's Cyclically Adjusted Revenue per Share of €5.43 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Centrum Medyczne ENEL-MED and its competitors. Centrum Medyczne ENEL-MED's current Cyclically Adjusted Revenue per Share is €5.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Centrum Medyczne ENEL-MED (FRA:E19) has a current Cyclically Adjusted Revenue per Share of €5.43. The stock's GF Value™ is €5.39, compared to a current price of €4.24 — trading 21.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €5.43. Centrum Medyczne ENEL-MED's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (FRA:E19), the current Cyclically Adjusted Revenue per Share is €5.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Centrum Medyczne ENEL-MED (FRA:E19) Overvalued in 2026?

Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued. The current stock price of €4.24 is trading 21.3% below its estimated GF Value™ of €5.39.

Key valuation signals for FRA:E19:

  • Cyclically Adjusted Revenue per Share: €5.43
  • GF Value™: €5.39 vs. price of €4.24 (21.3% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the FRA:E19 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Centrum Medyczne ENEL-MED Business Description

Other Exchanges ENE:Poland
Address ul. Slominskiego 19 lok. 524, Warsaw, POL, 00-195
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
76GF Score

Get the complete analysis for FRA:E19

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.24
Price
€5.39
GF Value